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Abstract Peroxisome proliferators (PPs) are non-genotoxic 
carcinogens in rodents. They can induce the expression of nu- 
merous genes via the heterodimerization of two members of the 
steroid hormone receptor superfamily, called the peroxisome 
profiferator-activated receptor (PPAR) and the 9-cis retinoic acid 
receptor (RXR). Many of the PP responsive genes possess a 
peroxisome pruliferator response lement (PPRE) formed by two 
TGACCT-related motifs. The bifunctional enzyme (liD) PPRE 
contains 3 such motifs, creating DR1 and DR2 sequences. PPAR 
and RXR regulate transcription via the DR1 element while DR2 
modulates the expression of the gene via auxiliary factors in 
HepG2 cells. 
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Transcriptional ctivation 
sists of direct repeats of the sequence TGACCT, the consensus 
binding sequence for several members of the nuclear steroid 
hormone receptor superfamily [7]. PPAR binds to these PPREs 
through eterodimerization with the 9-cis retinoic acid receptor 
RXR~ [4,8]. Transcriptional ctivation is regulated by diverse 
auxiliary transcription factors that can act as activators or 
repressors. For instance, the chicken ovalbumin upstream pro- 
moter-transcription factor (COUP-TF) can bind to the HD- 
PPRE and antagonizes peroxisome proliferators activation [9]. 
In fact, different studies on hormone response lements have 
shown that many known and unknown factors are able to bind 
promiscuous sequences [10-12]. Here we show that the PPAR- 
RXR heterodimer activates transcription via the DR1 part of 
the HD-PPRE and that other transcription factors modulate 
the level of induction via the most 5"-receptor motif in DR2. 
2. Materials and methods 
1. Introduction 
Peroxisomes are organelles involved in numerous important 
functions, including fatty acid t-oxidation. These reactions are 
essential for lipid homeostasis [1]. A group of compounds with 
diverse structures are able to provoke pleiotropic effects such 
as peroxisome proliferation and hepatocarcinogenesis in ro- 
dents: these compounds are termed peroxisome proliferators 
(PP). In rodents, PPs are able to regulate the transcription of
several genes important for lipid metabolism, such as rat per- 
oxisomal acyl-CoA oxidase (ACO) [2], rat peroxisomal enoyl- 
CoA hydratase/3-hydroxyacyl-CoA dehydrogenase (HD) [3,4] 
and rabbit microsomal cytochrome P-450 4A6 (CYP4A6) [5]. 
They do this via a nuclear eceptor termed the peroxisome 
proliferator activated receptor (PPAR), a member of the ster- 
oid hormone receptor superfamily [6]. These genes all contain 
a peroxisome proliferator response lement (PPRE) which con- 
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Abbreviations: ACO, rat peroxisomal cyl-CoA oxidase; ARP-1, 
ApoA1 regulatory protein; COUP-TF, chicken ovalbumin upstream 
promoter-transcription factor; CRBPII, cellular etinol binding protein 
II; DR1, direct repeats elements with 1-base spacing; DR2, direct re- 
peats elements with 2-base spacing; HD, rat peroxisomal enoyl-CoA 
hydratase/3-hydroxyacyl-CoA dehydrogenase; HNF4, hepatocyte nu- 
clear factor 4; Luc, luciferase; PP, peroxisome proliferator; PPAR~, 
peroxisome proliferator-activated r ceptor alpha; PPRE, peroxisome 
proliferator response element; RXR~, 9-cis retinoic acid receptor alpha. 
2.1. Plasmid construction 
pG.Luc is a luciferase xpression vector containing the rabbit fl- 
globin promoter [4]. Mutations of the HD-PPRE were derived from the 
synthetic oligonucleotides used to create the HD-PPRE.G.Luc [4]. The 
TGACCT-Iike motifs were replaced by the unique sequence ATCTGG 
giving three different oligonucleotides called AB, AC, BC in reference 
to the three TGACCT-like motifs A,B,C, of the HD-PPRE (Fig. 1): AB 
top strand, 5'-AGCTTTCCTTTGACCTATTGAACTAATCTGGAC- 
ATTGAG-Y; AC top strand, 5'-AGCTTTCCTI'TGACCTAT- 
ATCTGGATTACCTACATTGAG-Y; BC top strand, 5'-AGCTTT- 
CCTTATCTGGATrGAACTATTACCTACATTGAG-Y. Each dou- 
ble-stranded oligonucleotide was inserted between the HindlII and 
BamHI sites of pG.Luc. 
2.2. DNA-binding assays 
The different oligonucleotides (AB, AC, BC or HD-PPRE) were 
annealed and labelled with 32p using Klenow DNA polymerase and 
[32p]dCTP. Receptor proteins were synthetised from pSG5 expression 
vectors using the TNT rabbit reticulocytes in vitro transcription system 
(Promega). A typical DNA-binding assay [4] contained approximately 
75 fmol of mPPAR~ and/or mRXR~ in 10 mM HEPES pH 7.9, 50 mM 
KCI, 1 mM DTT, 2.5 mM MgCl2, 2/~g poly(dl • dC/dl • dC) (Pharmacia) 
and 10% glycerol in 10/~1 final volume. After 15 min on ice, radiola- 
belled oligonucleotides (30000 cpm, 25 fmol) and, when appropriate, 
unlabelled competitor ligonucleotides were added and incubation con- 
tinued at room temperature for 10 min. Reactions were loaded onto a 
prerun (30 min) 5% polyacrylamide slab gel equilibrated in0.5 × TBE 
and electrophoresed at 10 mA at 4°C for 1 h without buffer ecircula- 
tion. Finally, gels were soaked for 15 min in 5% (v/v) glycerol, dried and 
autoradiographed. The sequence ofthe unrelated competitor ligonu- 
cleotide is 5'-GATCTCCCAGGCTCTTCTCACGGAACTCCGGG- 
3'. 
2.3. Methylation interference assays 
A partially methylated probe was prepared by treating 0.5 pmol 
(2 × 106 cpm) [y-32p]ATP endqabelled double stranded oligonucleotide 
with 2% (v/v) dimethylsulphate for 5 min at 25°C in 50 mM Na Ca- 
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Fig. 1. Sequences of the modified oligonucleotides u ed in this study. AB, AC and BC are the names of the modified oligonucleotides. DR, direct 
repeat. 
HD-PPRE 
AB 
HD-PPRE 
AC 
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BC 
I| 
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IIIII 
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I 
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codylate pH 8.0, 1 mM EDTA. This probe was used in a preparative 
DNA-binding assay (scaled up 5 x), with in vitro translated proteins 
(mPPAR~ and mRXRc0, both 'protein-bound' and 'free' oligonucleo- 
tides were isolated by polyacrylamide g l electrophoresis and electroe- 
lution. Oligonucleotides were then cleaved by 1 M piperidine (90°C, 30 
min) and the resulting fragments separated on a 15% denaturing poly- 
acrylamide gel (2000 Cerenkov cpm per lane). The gel was autoradi- 
ographed without drying. A Maxam and Gilbert G + A chemical se- 
quencing reaction was performed in parallel [13]. 
2.4. TransJection assays 
HepG2 cells (a human hepatoblastoma cell line) were seeded in 
6-well dishes at 3 x 105 cells per well in Dulbecco's modified Eagle's 
medium (DMEM) supplemented with 10% foetal calf serum (FCS), 2 
mM glutamine and 0.1 mg/ml gentamycin. At 80% confluence, the cells 
were washed in serum free medium (DMEM without Phenol red) and 
transfected by mixing 5/.tg of plasmid DNA (Qiagen column purified) 
with 10 pg of Lipofectamine (Gibco-BRL) in 1 ml of serum-free and 
Phenol red-free medium which was applied to the cells [14]. Each well 
was transfected with 1 pg of luciferase reporter plasmid, 1 pg of expres- 
sion vector (pSG5 or pSG5-mPPARc 0 and 3 pg of the fl-galactosidase 
internal control plasmid pCH 110 (Pharmacia). After 5 h, 1 ml of Phenol 
red-free medium containing 20% dextran coated charcoal treated FCS 
was added together with either vehicle alone (0.1% DMSO) or the PP 
Wy-14,643 (Wyeth-Ayerst, Princeton, New Jersey, USA) prepared as 
1000× stocks in DMSO and used at 10 -5 M. After 24 hours, the cells 
were harvested in 300/4 of Reporter lysis buffer (Promega) and centri- 
fuged after one freeze-thaw cycle. The cleared cytosol extract (10 pl) 
was added to 50 pl of Luciferase assay reagent (Promega) and the light 
emission measured for 10 seconds in a TLX1 luminometer (Dynatech). 
fl-Galactosidase assays were performed using the Galacto-Light kit 
(Tropix, Bedford, MA, USA) as described by the supplier. The lucif- 
erase values were normalized using the fl-galactosidase values. 
3. Results 
Each of the modified oligonucleotides (AB, AC, BC) were 
tested in DNA-binding competit ion assays against he original 
Fig. 2. Gel-shift competition between labelled PPRE and unlabelled 
oligonucleotides AB, AC and BC. (1) Unprogrammed reticulocyte ly- 
sate; (2) in vitro translated PPAR and RXR; (3) competition with 
200-fold excess of unrelated oligonucleotide; x l, ×3, x l0, ×30 and 
×100, amount of unlabelled oligonucleotide added in the DNA- 
binding mix. The arrow indicates the position of the PPAR/RXR heter- 
odimer. 
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Fig. 3. Gel-shift with labelled oligonucleotides AB, AC and BC. (1) 
Unprogrammed reticulocyte lysate; (2) in vitro translated PPAR; (3) in 
vitro translated RXR; (4) in vitro translated PPAR and RXR. The 
arrow indicates the position of the PPAR/RXR heterodimer. 
HD-PPRE sequence (Fig. 2). mPPAR~ and mRXR~ were syn- 
thesized in vitro and incubated with a mixture of radiolabelled 
HD-PPRE and an increasing amount of each mutated oligonu- 
cleotide. The PPAR/RXR heterodimer is visible in lane 2 of 
Fig. 2. The AB oligonucleotide was unable to decrease the 
185 
binding at 100-fold molar excess, whereas the AC oligonucleo- 
tide competed at a 30-fold molar excess, and the BC oligonucle- 
otide competed for binding at 3-fold molar excess. The mutated 
oligonucleotides were then labelled and tested for DNA-bind- 
ing activity with PPAR, RXR or both (Fig. 3). As expected, AB 
was unable to support binding, AC demonstrated weak bind- 
ing, and BC bound to the PPAR-RXR heterodimer with high 
affinity. These results uggest that the presence of C is necessary 
for binding activity. 
Nucleotides important for binding were identified by methyl- 
ation interference. Using the AC oligonucleotide, based on 2 
different experiments, guanosine residues at -2946 and -2934 
were found to interact with the PPAR-RXR complex. Using 
the BC oligonucleotide, methylated guanosines at positions 
-2925, -2928, -2929 and -2935 prevented PPAR and RXR 
from binding, and methylated adenosine at position -2937 
(Fig. 4). 
Transfections activity of each sequence were carried out with 
the expression vector carrying mPPAR~, and the PP Wy- 
14,643 (Fig. 5). AB, having no DNA-binding ability, was una- 
ble to affect luciferase activity, as was AC. A striking effect 
was observed for BC, with a 70-fold induction over HD- 
PPRE.G.Luc or ACO(-570/-471).G.Luc activities, due to 
both a large increase in luciferase activity and a decrease of the 
basal expression of the reporter plasmid (excluding mPPARc~ 
and Wy-14,643). 
AC 
Sense Ant isense 
3'  G+A B F G+A B F 5 '  
, 
-2938 
-2937 
-2927 
3' 
BC 
Sense Ant lsense 
3' G+A B F G+A B F 
, 
-2935 
-2929 
-2928 
-2925 
5' 3 ~ 
Fig. 4. Methylation i terference of modified HD-PPRE: AC and BC. Sense and antisense sequences are indicated on each side. TGACCT-motifs 
are outlined. G + A, Maxam G + A sequencing; F, free oligonueleotides; B, bound oligonucleotides. 
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Fig. 5. Induction obtained with the different modified oligonucleotides 
in transfected HepG2 cells. The values indicated on x-axis are the fold 
induction of peroxisome proliferator (Wy-14,643) treated plates com- 
pared to the control plates (mean of three independent transfections; 
errors bars: standard eviation ).
4. Discussion 
These results upport and extend recent studies by ourselves 
[4] and others [9,15], showing the importance of the TGACCT 
related motifs. Moreover, we show the presence of both an 
activating (DR l) and modulating (DR2) sequence in the same 
response lement as an interesting feature of the transcriptional 
regulation of the HD gene. This phenomena is also observed 
in the regulation of the hApoAI gene [16] and the mCRBPI1 
gene [12]. Recent findings how that COUP-TF is able to bind 
to the 2 first motifs of this response lement [9]. Our present 
work now demonstrated that both TGACCT-Iike motifs in 
DR1 are critical and that no activation is possible if either is 
replaced. It is interesting that mPPAR~ and mRXRc~ can bind 
on the AC oligonucleotide with only 2 TGACCT motifs spaced 
by 9 bp. However, the nucleotide methylation of this sequence 
showed that the receptors bind by different nucleotides. The 
striking induction observed with the BC oligonucleotide is spe- 
cially interesting. This result constrasts with other results ob- 
tained with an oligonucleotide lacking the TGACCT-like motif 
A [9]. In the experiment by Miyata et al. (1993) [9], this oligonu- 
cleotide was shown to bind DNA but was unable to induce 
transcription of luciferase in transfections of rat hepatoma 
H4IIEC3 cells. Miyata's group has shown that COUP-TF 
binds as a homodimer to the HD-PPRE and does not form 
heterodimers with rPPAR~, RXR~ or HNF4. But in HepG2 
cells, it has been shown that HNF4 is present at higher levels 
than COUP-TF1 (Ear3) and COUP-TF2 (ARP-1) [17]. HNF4 
is constitutively expressed and activates everal promoters, 
such as mCRBPII [12] or hApoA1, [18] when COUP-TF1 or 
COUP-TF2 act as negative modulator of transcription. So, we 
assume that in HepG2 cells the increase of induction for the BC 
oligonucleotide may be due to the change of the recognition site 
in favor of an activatory effect (probably by HNF4). These 
results on HD-PPRE are consistent with a complex HRE 
formed of multiple recognition sites which interact with differ- 
ent transcription factors. The DR 1 is a PPRE and DR2, acts 
as a modulator of PPRE activity by binding of others factors 
(repressor or activator), that can lead to a differential response 
to PP. The role of the different factors interacting on the HD- 
PPRE but also on the upstream sequence of this gene has to 
be investigated to explain the peroxisome proliferator signalling 
pathway. 
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